Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
63,059.66 +30.18 (+0.05%) CMC Crypto 200
1,314.89 +37.91 (+2.97%)
Rigel Pharmaceuticals, Inc. (RIGL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 210.49M |
| Enterprise value | 214.13M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.79 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 1.83 |
| Enterprise value/EBITDA | -12.61 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.98 |
| 52-week change 3 | -3.36% |
| S&P500 52-week change 3 | 22.38% |
| 52-week high 3 | 1.9600 |
| 52-week low 3 | 0.7100 |
| 50-day moving average 3 | 1.3194 |
| 200-day moving average 3 | 1.1806 |
Share statistics
| Avg vol (3-month) 3 | 1.5M |
| Avg vol (10-day) 3 | 1.92M |
| Shares outstanding 5 | 175.4M |
| Implied shares outstanding 6 | 175.4M |
| Float 8 | 146.96M |
| % held by insiders 1 | 2.11% |
| % held by institutions 1 | 61.33% |
| Shares short (15 Apr 2024) 4 | 5.17M |
| Short ratio (15 Apr 2024) 4 | 3.31 |
| Short % of float (15 Apr 2024) 4 | 3.01% |
| Short % of shares outstanding (15 Apr 2024) 4 | 2.95% |
| Shares short (prior month 15 Mar 2024) 4 | 4.94M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:9 |
| Last split date 3 | 25 Jun 2003 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -21.67% |
| Operating margin (ttm) | 5.23% |
Management effectiveness
| Return on assets (ttm) | -10.73% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 115.78M |
| Revenue per share (ttm) | 0.67 |
| Quarterly revenue growth (yoy) | -27.60% |
| Gross profit (ttm) | N/A |
| EBITDA | -20.35M |
| Net income avi to common (ttm) | -25.09M |
| Diluted EPS (ttm) | -0.1400 |
| Quarterly earnings growth (yoy) | -47.40% |
Balance sheet
| Total cash (mrq) | 56.93M |
| Total cash per share (mrq) | 0.32 |
| Total debt (mrq) | 104.17M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 1.86 |
| Book value per share (mrq) | -0.16 |
Cash flow statement
| Operating cash flow (ttm) | -5.74M |
| Levered free cash flow (ttm) | -25.82M |
© 2024 Yahoo. All rights reserved.